Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |